Beximco Pharmaceuticals Limited., the leading manufacturer and exporter of medicines in Bangladesh, has recently received GMP (Good Manufacturing Practices) approval from the Canadian regulatory authority, Health Canada.
This is for the first time a Bangladeshi company has received this prestigious approval. This opens a new marketing opportunity for Beximco Pharma in the Canadian market and, similar to many other developed countries, Canada is increasingly promoting access to generic drugs.
Nazmul Hassan MP, Managing Director of Beximco Pharma, said, “Canada is an important market for us and this approval marks a significant milestone for the Company, further validating our high standards of quality and compliance practices. This approval builds on our existing presence in key regulated markets and is an important step towards our aspiration to become a global generic drug player.’’
Beximco Pharma is certified by the EU regulatory authority, where the Company has been exporting medicines since 2013, and has received approvals from the relevant authorities in Australia, Latin America, Gulf Nations, and South Africa, among others. In addition, the Company has won the National Export Trophy (Gold), the highest national accolade for export, a record four times for its outstanding contribution to the country’s export.